Patent Applications for OSILODROSTAT PHOSPHATE

✉ Email this page to a colleague

US Patent Applications for OSILODROSTAT PHOSPHATE

Subscribe to access the full database, or Subscribe
US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
⤷ Subscribe	⤷ Subscribe	USE OF AN ADRENAL HORMONE-MODIFYING AGENT	2012-07-11	Patented Case	2013-11-26
⤷ Subscribe	⤷ Subscribe	NEW FORMS AND SALTS OF A DIHYDROPYRROLO[1,2C]IMIDAZOLYL ALDOSTERONE SYNTHASE OR AROMATASE INHIBITOR	2014-07-01	Publications -- Issue Fee Payment Verified	2016-04-08
⤷ Subscribe	⤷ Subscribe	Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor	2016-02-09	Abandoned -- Failure to Respond to an Office Action	2019-05-09
>US Patent Application	>Patent No.	>Title	>Patent Filing Date	>Patent Application Status	>Status Updated

Japanese Patent Applications for OSILODROSTAT PHOSPHATE

Subscribe to access the full database, or Subscribe
JP Patent Application	Title	Patent Filing Date
⤷ Subscribe
>JP Patent Application	>Title	>Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.